Licensing

Veterinary medicines are licensed.

A licence means that veterinary medicines only reach the marketplace once their safety, quality and efficacy are clearly demonstrated, and after review by the relevant authorities.

  • Safety: A veterinary product must be safe for animals, consumers, users (farmers, vets, pet owners, etc.), and the environment in order to qualify for a marketing authorisation or licence.
    These criteria are imposed stringently and animal health companies must conduct in-depth studies and provide detailed data demonstrating the safety of their medicines.
  • Quality: A manufacturer must demonstrate not only the quality of a finished product, but also the consistent quality of the raw materials and manufacturing processes involved in its production.
    The product must be stable, which means that its quality and efficacy is ensured at least until the stated ‘best before’ date.
  • Efficacy: A manufacturer must substantiate claims regarding the effectiveness of a product. They must demonstrate through detailed field trials that the product is effective in preventing or treating a medical condition, in accordance with the statements made on the product labeling and information sheets.

Regulatory framework

Each EU Member State has its own independent regulatory authority, which performs independent scientific evaluations of veterinary medicines. Additionally, the European Medicines Agency, based in London, is a pan-EU regulatory agency for human and veterinary medicines.

The registration requirements for all EU Member States have been harmonised. However, some medicines are only needed in certain Member States due to the geographical location of certain diseases or to climate conditions.

The system is therefore flexible and includes four different routes through which a licence can be obtained:

  • The national procedure
  • The mutual recognition procedure
  • The centralised procedure
  • The decentralised procedure.

Further information

Veterinary medicine license

Downloads
  • PathwayToNewVetMedicines (1.05 MB) Download

Latest tweet

  • 18 November
    RT @COPACOGECA: @EAAD_EU @ECDC_EU EU farmers & agri-coops committed to assuring responsible use of medicines in #animals ➡ guaranteeing saf…
  • 18 November
    EPRUMA@epruma1
    An inspiring message from @V_Andriukaitis on #EAAD: yes! says #epruma https://t.co/23HXBDtSHb
  • 18 November
    EPRUMA@epruma1
    RT @EU_Health: #EAAD Closing words by Andrea Ammon @ECDC_EU "It is the sustained joint effort of all of us that will bring results" https:/…

LATEST PUBLICATIONS

  • On European Antibiotic Awareness Day 2017, EPRUMA's Chairman, Rens van Dobbenburgh, explains what our platform

  • On European Antibiotic Awareness Day (18 November 2016)  EPRUMA's Chairman, Rens van Dobbenburgh, pledges to

  • EPRUMA declaration on 'Our 7 commitments to the responsible use of veterinary medicines': signed in Brussels

  • download